Business Context and Reporting Period
Company: Integer Holdings Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: July 2, 2018
Event: Completion of the sale of the Advanced Surgical and Orthopedic (AS&O) product lines to Bandera Acquisition, LLC (a subsidiary of MedPlast, LLC).
Key Financial Metrics
- Transaction Consideration: $600.0 million in cash.
- Price Adjustments: The purchase price is subject to reduction by the net indebtedness of the AS&O Business at closing and an increase by the amount of retained accounts payable to be paid by the Company. A final closing statement will determine the final adjustment.
- Executive Compensation: A success bonus of $845,000 was awarded to Declan Smyth (former President, Advanced Surgical & Orthopedics) for contributions to the sale.
- Other Metrics: The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity for the reporting period, as this is a transactional report rather than a periodic financial statement.
Material Changes
- Asset Disposition: The Company divested its Advanced Surgical and Orthopedic product lines, significantly altering its business portfolio.
- Personnel Changes: Declan Smyth's employment with Integer Holdings terminated upon the sale's completion; he is now employed by the Purchaser.
- Financial Impact: The transaction results in a significant cash inflow (subject to adjustments) and the removal of the AS&O Business assets and liabilities from the Company's balance sheet.
Guidance, Outlook, and Risks
- Pro Forma Information: Unaudited pro forma consolidated financial information giving effect to the sale is included as Exhibit 99.2.
- Contingencies: The final purchase price is contingent upon the final closing statement regarding net indebtedness and retained accounts payable.
- Management Commentary: The filing references a press release (Exhibit 99.1) for further details on the transaction but does not contain specific forward-looking guidance or risk factors within the text provided.
Investor Verification Checklist
- Review the Master Purchase and Sale Agreement (Exhibit 2.1) for specific definitions of net indebtedness and retained accounts payable affecting the final purchase price.
- Examine the Unaudited Pro Forma Consolidated Financial Information (Exhibit 99.2) to understand the post-transaction financial position.
- Verify the final closing statement to confirm the actual cash consideration received after adjustments.
- Assess the strategic impact of removing the AS&O Business on the Company's remaining product lines and future growth strategy.